{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:25:34Z","timestamp":1793409934312,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116937","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T21:49:44Z","timestamp":1728510584000},"page":"116937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Discovery of glycosidated glycyrrhetinic acid derivatives: Natural product-based soluble epoxide hydrolase inhibitors"],"prefix":"10.1016","volume":"280","author":[{"given":"Qian","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Hao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Zhen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Meng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1309-8521","authenticated-orcid":false,"given":"Jian-Hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116937_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/13880209.2016.1225775","article-title":"The anti-inflammatory activity of licorice, a widely used Chinese herb","volume":"55","author":"Yang","year":"2016","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2024.116937_bib2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.21037\/jtd.2019.04.14","article-title":"Effects of glycyrrhizin on lipopolysaccharide-induced acute lung injury in a mouse model","volume":"11","author":"Lee","year":"2019","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ejmech.2024.116937_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejmech.2017.08.002","article-title":"Novel unsaturated glycyrrhetic acids derivatives: design, synthesis and anti-inflammatory activity","volume":"139","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib4","doi-asserted-by":"crossref","first-page":"104461","DOI":"10.1016\/j.bioorg.2020.104461","article-title":"Structure-based design of glycyrrhetinic acid derivatives as potent anti-sepsis agents targeting high-mobility group box-1","volume":"106","author":"Wang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib5","doi-asserted-by":"crossref","first-page":"105542","DOI":"10.1016\/j.bioorg.2021.105542","article-title":"Synthesis and anti-inflammatory activities of glycyrrhetinic acid derivatives containing disulfide bond","volume":"119","author":"Zhang","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib6","doi-asserted-by":"crossref","first-page":"115696","DOI":"10.1016\/j.ejmech.2023.115696","article-title":"Synthesis of glycyrrhizin analogues as HMGB1 inhibitors and their activity against sepsis in acute kidney injury","volume":"259","author":"Qiang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2008.03.057","article-title":"Evaluation of COX-1\/COX-2 selectivity and potency of a new class of COX-2 inhibitors","volume":"588","author":"Gierse","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116937_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1745-7254.2005.00150.x","article-title":"Is COX-2 a perpetrator or a protector? Selective COX-2 inhibitors remain controversial1","volume":"26","author":"Luo","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2024.116937_bib9","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1100\/tsw.2005.82","article-title":"Adverse effects of COX-2 inhibitors","volume":"5","author":"Sharma","year":"2005","journal-title":"Sci. World J."},{"key":"10.1016\/j.ejmech.2024.116937_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prostaglandins.2011.08.001","article-title":"Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception","volume":"96","author":"Wagner","year":"2011","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.ejmech.2024.116937_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1021\/acs.jmedchem.0c01507","article-title":"Discovery of soluble epoxide hydrolase inhibitors from chemical synthesis and natural products","volume":"64","author":"Sun","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib12","doi-asserted-by":"crossref","first-page":"9201","DOI":"10.1021\/acs.jmedchem.3c00831","article-title":"Design, synthesis, and pharmacological characterization of a potent soluble epoxide hydrolase inhibitor for the treatment of acute pancreatitis","volume":"66","author":"Musella","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib13","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1021\/acs.jmedchem.2c01996","article-title":"Structure-directed discovery of potent soluble epoxide hydrolase inhibitors for the treatment of inflammatory diseases","volume":"66","author":"Chen","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib14","doi-asserted-by":"crossref","first-page":"13660","DOI":"10.1021\/acs.jmedchem.2c00515","article-title":"Synthesis, in vitro profiling, and in vivo evaluation of benzohomoadamantane-based ureas for visceral pain: a new indication for soluble epoxide hydrolase inhibitors","volume":"65","author":"Codony","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib15","doi-asserted-by":"crossref","first-page":"14456","DOI":"10.1021\/acs.jmedchem.2c00817","article-title":"Discovery and optimization of indoline-based compounds as dual 5-LOX\/sEH inhibitors: in vitro and in vivo anti-inflammatory characterization","volume":"65","author":"Cerqua","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib16","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1021\/acs.jmedchem.3c02006","article-title":"Design and synthesis of dual-targeting inhibitors of sEH and HDAC6 for the treatment of neuropathic pain and lipopolysaccharide-induced mortality","volume":"67","author":"Chen","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib17","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0163-7827(03)00049-3","article-title":"Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function","volume":"43","author":"Spector","year":"2004","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.ejmech.2024.116937_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2018.01.010","article-title":"Metabolic\/inflammatory\/vascular comorbidity in psychiatric disorders; soluble epoxide hydrolase (sEH) as a possible new target","volume":"87","author":"Swardfager","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2024.116937_bib19","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/0091270010397049","article-title":"Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single\u2010and multiple\u2010dose studies in healthy human subjects","volume":"52","author":"Chen","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116937_bib20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s12028-021-01398-8","article-title":"Placebo-controlled trial of soluble epoxide hydrolase inhibition in patients with aneurysmal subarachnoid hemorrhage","volume":"36","author":"Martini","year":"2022","journal-title":"Neurocrit. Care"},{"key":"10.1016\/j.ejmech.2024.116937_bib21","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/HYPERTENSIONAHA.121.17659","article-title":"GSK2256294 decreases sEH (soluble epoxide hydrolase) activity in plasma, muscle, and adipose and reduces F2-Isoprostanes but does not alter Insulin sensitivity in humans","volume":"78","author":"Luther","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ejmech.2024.116937_bib22","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1021\/acs.jmedchem.0c01886","article-title":"Movement to the clinic of soluble epoxide hydrolase inhibitor EC5026 as an analgesic for neuropathic pain and for use as a nonaddictive opioid alternative","volume":"64","author":"Hammock","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib23","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116937_bib24","doi-asserted-by":"crossref","first-page":"9237","DOI":"10.1021\/acs.jmedchem.0c00310","article-title":"2-Oxaadamant-1-yl ureas as soluble epoxide hydrolase inhibitors: in vivo evaluation in a murine model of acute pancreatitis","volume":"63","author":"Codony","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib25","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1021\/acs.jmedchem.0c01601","article-title":"From the design to the in vivo evaluation of benzohomoadamantane-derived soluble epoxide hydrolase inhibitors for the treatment of acute pancreatitis","volume":"64","author":"Codony","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20451253211024873","article-title":"Liquorice for pain?","volume":"11","author":"Bell","year":"2021","journal-title":"Ther. Adv. Psychopharm."},{"key":"10.1016\/j.ejmech.2024.116937_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1021\/acs.jnatprod.5b00641","article-title":"18\u03b2-Glycyrrhetinic acid derivatives possessing a Trihydroxylated A ring are potent gram-positive antibacterial agents","volume":"79","author":"Huang","year":"2016","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2024.116937_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18138-9","article-title":"Site-selective C-H hydroxylation of pentacyclic triterpenoids directed by transient chiral pyridine-imino groups","volume":"11","author":"Mu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116937_bib29","doi-asserted-by":"crossref","first-page":"104755","DOI":"10.1016\/j.bioorg.2021.104755","article-title":"Design and synthesis of novel glycyrrhetin ureas as anti-inflammatory agents for the treatment of acute kidney injury","volume":"110","author":"Wang","year":"2021","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib30","doi-asserted-by":"crossref","first-page":"13676","DOI":"10.1021\/acs.jmedchem.1c01019","article-title":"Synthesis and biological evaluation of C-17-amino-substituted pyrazole-fused betulinic acid derivatives as novel agents for osteoarthritis treatment","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib31","doi-asserted-by":"crossref","first-page":"116113","DOI":"10.1016\/j.ejmech.2023.116113","article-title":"Discovery of a novel lead characterized by a stilbene-extended scaffold against sepsis as soluble epoxide hydrolase inhibitors","volume":"266","author":"Feng","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib32","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1016\/j.neuron.2023.06.002","article-title":"Hepatic soluble epoxide hydrolase activity regulates cerebral A\u03b2 metabolism and the pathogenesis of Alzheimer's disease in mice","volume":"111","author":"Wu","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2024.116937_bib33","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1021\/acs.bioconjchem.3c00120","article-title":"Glycosylation improves the proteolytic stability of exenatide","volume":"34","author":"Chandrashekar","year":"2023","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41522-023-00468-3","article-title":"Impact of structurally diverse polysaccharides on colonic mucin O-glycosylation and gut microbiota","volume":"9","author":"Zhao","year":"2023","journal-title":"npj Biofilms and Microbiomes"},{"key":"10.1016\/j.ejmech.2024.116937_bib35","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1039\/D2NP00077F","article-title":"Plant glycosyltransferases for expanding bioactive glycoside diversity","volume":"40","author":"Sirirungruang","year":"2023","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2024.116937_bib36","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","article-title":"Global view of human protein glycosylation pathways and functions","volume":"21","author":"Schjoldager","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2024.116937_bib37","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1039\/C7MD00210F","article-title":"18\u03b1-Glycyrrhetinic acid monoglucuronide as an anti-inflammatory agent through suppression of the NF-\u03baB and MAPK signaling pathway","volume":"8","author":"Li","year":"2017","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2024.116937_bib38","doi-asserted-by":"crossref","first-page":"112932","DOI":"10.1016\/j.ejmech.2020.112932","article-title":"Synthesis and anti-inflammatory activity of saponin derivatives of \u03b4-oleanolic acid","volume":"209","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib39","doi-asserted-by":"crossref","first-page":"12196","DOI":"10.1021\/ja9926818","article-title":"First synthesis of a bidesmosidic triterpene saponin by a highly efficient procedure","volume":"121","author":"Yu","year":"1999","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2024.116937_bib40","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.carres.2009.04.024","article-title":"Facile synthesis of three bidesmosidic oleanolic acid saponins with strong inhibitory activity on pancreatic lipase","volume":"344","author":"Guo","year":"2009","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ejmech.2024.116937_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202200818","article-title":"Total synthesis and stereochemistry assignment of nucleoside antibiotic A\u201094964","volume":"61","author":"Shao","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2024.116937_bib42","doi-asserted-by":"crossref","first-page":"9405","DOI":"10.1016\/j.tet.2012.09.015","article-title":"Synthesis and evaluation of glucosamine-6-phosphate analogues as activators of glmS riboswitch","volume":"68","author":"Wang","year":"2012","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2024.116937_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1081\/CAR-120014899","article-title":"An efficient and practical synthesis of \u03b1-(1\u21923)-linked mannohexaose and mannooctaose","volume":"21","author":"Chen","year":"2006","journal-title":"J. Carbohydr. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib44","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1021\/acs.joc.6b02873","article-title":"1JCH NMR Profile: identification of key structural features and functionalities by visual observation and direct measurement of one-bond proton-carbon coupling constants","volume":"82","author":"Marc\u00f3","year":"2017","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib45","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.1016\/S0040-4020(98)00426-8","article-title":"Direct chemical synthesis of 13-mannopyranosides and other glycosides via giycosyl triflates","volume":"54","author":"Crich","year":"1998","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2024.116937_bib46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1124\/mol.114.097501","article-title":"Soluble epoxide hydrolase pharmacological inhibition ameliorates experimental acute pancreatitis in mice","volume":"88","author":"Bettaieb","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116937_bib47","article-title":"Effects of soluble epoxide hydrolase deficiency on acute pancreatitis in mice","volume":"9","author":"Schneider","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2024.116937_bib48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2021.09.043","article-title":"Global incidence of acute pancreatitis Is increasing over time: a systematic review and meta-analysis","volume":"162","author":"Iannuzzi","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejmech.2024.116937_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2022.1077414","article-title":"Fire in the belly: a scoping review of the immunopathological mechanisms of acute pancreatitis","volume":"13","author":"Venkatesh","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejmech.2024.116937_bib50","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1365-2567.2003.01715.x","article-title":"5\u2010lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein","volume":"110","author":"Cuzzocrea","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.ejmech.2024.116937_bib51","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1440-1746.2006.04752.x","article-title":"Elevated level of interleukin\u20106 predicts organ failure and severe disease in patients with acute pancreatitis","volume":"22","author":"Sathyanarayan","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejmech.2024.116937_bib52","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejmech.2024.116937_bib53","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bbalip.2014.07.020","article-title":"Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism","volume":"1851","author":"Spector","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.ejmech.2024.116937_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/1476-511X-12-151","article-title":"The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins","volume":"12","author":"Yang","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.ejmech.2024.116937_bib55","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.bmcl.2018.01.003","article-title":"Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase","volume":"28","author":"Kodani","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2024.116937_bib56","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.bmc.2014.03.001","article-title":"Structural insights into binding of inhibitors to soluble epoxide hydrolase gained by fragment screening and X-ray crystallography","volume":"22","author":"Amano","year":"2014","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib57","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1021\/jm500694p","article-title":"Optimized inhibitors of soluble epoxide hydrolase improve in vitro target residence time and in vivo efficacy","volume":"57","author":"Lee","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib58","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.drudis.2015.04.005","article-title":"Successful generation of structural information for fragment-based drug discovery","volume":"20","author":"\u00d6ster","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2024.116937_bib59","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.3390\/molecules29133036","article-title":"Evaluation of the therapeutic potential of sulfonyl urea derivatives as soluble epoxide hydrolase (sEH) inhibitors","volume":"29","author":"Kundu","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2024.116937_bib60","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/acsomega.2c06936","article-title":"Benzoxazolone-5-urea derivatives as human soluble epoxide hydrolase (sEH) inhibitors","volume":"8","author":"Gur Maz","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2024.116937_bib61","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/BF00332483","article-title":"Cytosolic epoxide hydrolase in humans: development and tissue distribution","volume":"62","author":"Pacifici","year":"1988","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.ejmech.2024.116937_bib62","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0006-2952(80)90518-3","article-title":"Distribution and properties of a mammalian soluble epoxide hydrase","volume":"29","author":"Gill","year":"1980","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116937_bib63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.fitote.2015.10.013","article-title":"Alkylphloroglucinol derivatives and triterpenoids with soluble epoxide hydrolase inhibitory activity from Callistemon citrinus","volume":"109","author":"Khanh","year":"2016","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2024.116937_bib64","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1016\/j.celrep.2019.11.006","article-title":"Liver soluble epoxide hydrolase regulates behavioral and cellular effects of chronic stress","volume":"29","author":"Qin","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2024.116937_bib65","first-page":"16747","article-title":"The antiinflammatory effect of laminar flow: the role of PPAR\u03b3, epoxyeicosatrienoic acids, and soluble epoxide hydrolase","volume":"102","author":"Liu","year":"2005","journal-title":"PANS (Pest. Artic. News Summ.)"},{"key":"10.1016\/j.ejmech.2024.116937_bib66","doi-asserted-by":"crossref","first-page":"112662","DOI":"10.1016\/j.ejmech.2020.112662","article-title":"Discovery of novel urea-diarylpyrazole hybrids as dual COX-2\/sEH inhibitors with improved anti-inflammatory activity and highly reduced cardiovascular risks","volume":"205","author":"Abdelazeem","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib67","doi-asserted-by":"crossref","first-page":"9550","DOI":"10.1021\/acs.jmedchem.1c00880","article-title":"Design, synthesis, and activity evaluation of stereoconfigured tartarate derivatives as potential anti-inflammatory agents in vitro and in vivo","volume":"64","author":"Kumari","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"[20] Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.ejmech.2024.116937_bib69","doi-asserted-by":"crossref","first-page":"30370","DOI":"10.1074\/jbc.274.43.30370","article-title":"Conformational flexibility of the acetylcholinesterase tetramer suggested by X-ray crystallography","volume":"274","author":"Bourne","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2024.116937_bib70","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.str.2009.03.001","article-title":"Synergy of NMR, computation, and X-Ray crystallography for structural biology","volume":"17","author":"Szymczyna","year":"2009","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2024.116937_bib71","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1107\/S0907444909011548","article-title":"Generalized X-ray and neutron crystallographic analysis: more accurate and complete structures for biological macromolecules","volume":"65","author":"Adams","year":"2009","journal-title":"Acta Crystallogr., Sect D: Biol. Crystallogr."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T06:22:57Z","timestamp":1732170177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424008183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":71,"alternative-id":["S0223523424008183"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116937","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of glycosidated glycyrrhetinic acid derivatives: Natural product-based soluble epoxide hydrolase inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116937","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116937"}}